Decoy Therapeutics: Q3 Earnings Snapshot

Barchart · 3d ago

HOUSTON (AP) — HOUSTON (AP) — Decoy Therapeutics Inc. (DCOY) on Thursday reported a loss of $3 million in its third quarter.

The Houston-based company said it had a loss of $3.53 per share.

The biotech drug developer posted revenue of $307,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DCOY at https://www.zacks.com/ap/DCOY